Cochrane Review 2026 Follow‑up Analysis: CBD Monotherapy Insufficient for Neuropathic Pain — Combination with THC Appears More Effective

A follow‑up analysis to the Cochrane Review 2026 concluded that CBD administered alone does not demonstrate adequate efficacy for the treatment of neuropathic pain. Accumulating evidence indicates that combination therapies including THC are more effective than CBD monotherapy.

For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.